Home
Product
FDF
API
About Us
Profiles
Video
Honor
News
Contact Us
中
/
EN
Home
Product
FDF
API
About Us
Profiles
Video
Honor
News
Contact Us
Congratulations to the approval of API Norepinephrine Bitartrate!
Wanhan Pharmaceutical Company 丨 visit us at booth No.6 in the 18th Annual Meeting of the Chinese Physicians Association of Ophthalmology
Wanhan Pharmaceutical Company 丨 Visit us at Booth A4E46 during the 89th PharmChina.
Wanhan Pharmaceutical Company 丨 Visit us at Booth B17 during the 10th Chinese Dry Eye Congress.
WANHAN PHARMACEUTICAL COMPANY: Landiolol Hydrochloride API has been successfully authorized.
Diquafosol sodium eye drops have been officially approved
We invite you to visit the 28th Chinese Medical Association Ophthalmology Conference stand A4008 for guidance and negotiation
We invite you to visit our booth P03 to guide and negotiate
1
2
3
4
5